US Patent Number

5612030

Publication Date

3-18-1997

Abstract

The present invention relates isolation of anti-idiotypic antibody 1A7 raised against anti-GD2 mAb 14G2a and its use for the treatment of melanoma and small cell carcinoma. The antibody may be used as a substitute for isolated purified GD2 antigen in any appropriate application.

Assignees

University of Kentucky Research Foundation, Lexington, Ky.

Application Number

372,676

Filing Date

01/17/1995

Share

COinS